Overview

The Safety and Preliminary Tolerability of Lyophilized Lucinactant in Adults With Coronavirus Disease 2019 (COVID-19)

Status:
Recruiting
Trial end date:
2022-01-30
Target enrollment:
Participant gender:
Summary
This is a multicenter, single-treatment study. Subjects will consist of adults with COVID-19 associated acute lung injury who are being cared for in a critical care environment.
Phase:
Phase 2
Details
Lead Sponsor:
Windtree Therapeutics
Treatments:
Pulmonary Surfactants